Tag: Drug Pricing

Trump’s Drug Pricing Czar Found With ‘Multiple Blunt Force Injuries,’ Ruled Suicide | The Epoch Times

Trump’s Drug Pricing Czar Found With ‘Multiple Blunt Force Injuries,’ Ruled Suicide | The Epoch Times

The high-level federal official tasked with lowering drug prices was found dead and, according to authorities in Washington, took his own life. Daniel Best was the senior adviser to Alex Azar, secretary of Health and Human Services (HHS), for drug pricing reform. … Two days before his death, HHS published a question-and-answer article where Best explained […]

Health IT Adoption of Surescripts Price Transparency Tool Surges | EHR Intelligence

Health IT Adoption of Surescripts Price Transparency Tool Surges | EHR Intelligence

November 16, 2018 – Surescripts is experiencing a surge in new users as health IT adoption of its Real-Time Prescription Benefit tool increases fortyfold in a year. Prescribers have so far used the tool 30 million times to view patient-specific price and therapeutic alternative information since the EHR-integrated tool’s launch in 2017. EHR vendors comprising 77 […]

Pfizer preps a laundry list of drug price hikes for the New Year — let the political fireworks begin | Endpoints News

Pfizer preps a laundry list of drug price hikes for the New Year — let the political fireworks begin | Endpoints News

Pfizer is billing this as a re­strained and com­pletely rea­son­able move, but the pharma giant has just thrown down a gaunt­let beg­ging Pres­i­dent Don­ald Trump to pick it up. On Fri­day af­ter­noon the pharma giant $PFE put out a state­ment say­ing that it’s hold­ing the price line on 90% of its drug port­fo­lio come the […]

Something Happened to U.S. Drug Costs in the 1990s | The New York Times

Something Happened to U.S. Drug Costs in the 1990s | The New York Times

Another potential explanation is that Americans take more expensive brand-name drugs than cheaper generics relative to their overseas counterparts. This doesn’t hold up either. We use a greater proportion of generic drugs here than most other countries — 84 percent of prescriptions are generic. Though Americans take a lower proportion of brand-name drugs, the prices […]

Congress should broaden legislation to curb medical price gouging | TheHill

Congress should broaden legislation to curb medical price gouging | TheHill

Washington is taking notice of an important problem: hospital price gouging of unsuspecting patients. The No More Surprise Medical Bills Act of 2018, introduced last month by Democratic Sens. Maggie Hassan and Jeanne Shaheen of New Hampshire, followed a bill offered earlier this year by six senators, the bipartisan Protecting Patients from Surprise Medical Bills […]

Dem overtures to Trump on drug pricing worry pharma | TheHill

Dem overtures to Trump on drug pricing worry pharma | TheHill

The Democratic takeover of the House is giving new life to efforts to fight high drug prices with bipartisan action, a worrying prospect for the pharmaceutical industry. It’s a top priority for House Democrats, who now have powers to press the issue and put the drug industry on the hot seat. It’s also an issue […]

Split Congress to Attack Drug Pricing | Pharmaceutical Executive

Split Congress to Attack Drug Pricing | Pharmaceutical Executive

Healthcare was the deciding issue for more than 40 percent of voters in the mid-term elections, setting the stage for action on Capitol Hill to further challenge too-high prescription drug prices. Concerns over access to affordable care helped Democrats take control of the House. And even though Republicans increased their majority in the Senate, they […]

Tale of 2 CEOs: Merck chief treads carefully on pricing, while Pfizer’s Read predicts more hikes | FiercePharma

Tale of 2 CEOs: Merck chief treads carefully on pricing, while Pfizer’s Read predicts more hikes | FiercePharma

Two Big Pharma CEOs have sounded off on drug pricing, and what a difference between the two. Merck’s Ken Frazier stayed in safe territory with his barbs against rebates, but Pfizer’s Ian Read touched off controversy by predicting a return to price hikes. During separate sets of remarks this week, Frazier took a line that’s […]

Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure | Reuters

Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure | Reuters

COPENHAGEN (Reuters) – Novo Nordisk (NOVOb.CO), the world’s top maker of diabetes drugs, reported encouraging sales of its main growth drivers on Thursday as it announced more job cuts amid a restructuring to cope with intensifying pricing pressure in the United States. The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the […]

Merck CEO on US healthcare system and drug pricing [Video] | CNBC

Merck CEO on US healthcare system and drug pricing [Video] | CNBC

Merck CEO Ken Frazier discusses the U.S. healthcare system and President Donald Trump’s drug pricing plan. Read complete article here: Merck CEO on US healthcare system and drug pricing.